webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

mPEG11-amine

  CAS No.: 854601-60-8   Cat No.: BADC-01167   Purity: ≥95% 4.5  

mPEG11-amine is a monofunctional amine-terminated PEG linker used in ADC design to enhance hydrophilicity and pharmacokinetics. Suitable for single-point conjugation and surface modification.

mPEG11-amine

Structure of 854601-60-8

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C23H49NO11
Molecular Weight
515.64
Shipping
Room temperature, or blue ice upon request.
Storage
Store at 2-8°C

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
m-PEG11-amine; mPEG11-NH2; 2,5,8,11,14,17,20,23,26,29,32-Undecaoxatetratriacontan-34-amine; 3,6,9,12,15,18,21,24,27,30,33-Undecaoxatetratriacontan-1-amine
IUPAC Name
2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanamine
Canonical SMILES
COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCN
InChI
InChI=1S/C23H49NO11/c1-25-4-5-27-8-9-29-12-13-31-16-17-33-20-21-35-23-22-34-19-18-32-15-14-30-11-10-28-7-6-26-3-2-24/h2-24H2,1H3
InChIKey
SWAJVHMMXALQKJ-UHFFFAOYSA-N
Density
1.070±0.06 g/cm3 (Predicted)
Solubility
Soluble in DMSO (10 mm)
PSA
127.55000
Appearance
Pale Yellow or Colorless Oily Liquid
Shelf Life
-20°C 3 years powder; -80°C 2 years in solvent
Shipping
Room temperature, or blue ice upon request.
Storage
Store at 2-8°C
Boiling Point
551.9±45.0 °C at 760 mmHg
Form
Solid
Biological Activity
m-PEG11-Amino is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[1] . In Vitro: ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker.

mPEG11-amine, a versatile polyethylene glycol derivative, finds extensive application in the biosciences. Here are four key applications of mPEG11-amine:

Drug Delivery: Positioned at the forefront of drug delivery innovation, mPEG11-amine serves as a pivotal linker in the creation of drug delivery systems, especially in conjugating therapeutic molecules like peptides and proteins. Its inherently hydrophilic properties enhance drug solubility and stability, prolonging circulation time within the body. This optimization leads to heightened bioavailability and diminished immunogenicity, rendering mPEG11-amine indispensable in pharmaceutical endeavors.

Bioconjugation: Playing a pivotal role in biochemistry and molecular biology, mPEG11-amine emerges as a versatile reagent for diverse bioconjugation techniques. Its utility lies in attaching fluorescent dyes or antibodies to biomolecules, facilitating seamless labeling and detection in a variety of assays and imaging applications. The unique amine group enables precise and robust covalent bonding, ensuring stable conjugation conditions essential for accurate research outcomes.

Surface Modification: Embraced for surface modification strategies, mPEG11-amine contributes significantly to enhancing the biocompatibility and functionality of various materials. By coating surfaces with this compound, researchers effectively curtail protein adsorption and cell adhesion, pivotal aspects in medical device and implant technology. This transformative modification elevates material performance and longevity within biological settings, underscoring its critical role in advancing biomedical technologies.

Protein Stabilization: In the realm of protein research, mPEG11-amine emerges as a stalwart in stabilizing proteins during storage and handling procedures. Its PEG backbone acts as a shield against protein aggregation and denaturation, preserving protein activity and integrity over prolonged durations. This distinctive attribute proves invaluable in bolstering the stability of therapeutic proteins and enzymes, ensuring their optimal efficacy across diverse applications.

What is mPEG11-amine and its application in ADC linkers?

mPEG11-amine is a monodisperse polyethylene glycol derivative with a terminal amine group, used as a spacer or hydrophilic linker in ADCs. It enhances solubility, reduces aggregation, and allows conjugation to NHS esters or activated carboxyl groups on antibodies.

2/11/2020

We would like to know how mPEG11-amine can improve ADC properties.

The PEG11 spacer increases hydrophilicity and flexibility of ADCs, reducing steric hindrance, minimizing immunogenicity, and enhancing circulation half-life, while maintaining efficient payload delivery to target cells.

9/3/2019

Could you kindly advise which types of payloads can be attached using mPEG11-amine?

It can conjugate NHS-activated cytotoxins, peptides, and fluorophores. The terminal amine enables stable linkage formation while the PEG11 chain improves solubility and reduces aggregation in ADC formulations.

9/9/2021

Good morning! Could you please advise the recommended conjugation conditions for mPEG11-amine?

Conjugation is performed in slightly basic buffers (pH 7–8.5) or mixed organic-aqueous solvents at controlled temperatures to optimize reaction efficiency and maintain antibody and payload integrity.

3/4/2022

Good afternoon! Which supporting documents are provided to verify the identity and quality of mPEG11-amine?

BOC Sciences provides mPEG11-amine with a Certificate of Analysis, NMR spectra, and mass spectrometry data. These documents confirm molecular identity and structural integrity, supporting reproducibility and analytical verification for research applications. Full documentation is available upon request.

9/6/2022

— Dr. Matthew Green, Biochemist (UK)

mPEG11-amine offered excellent solubility and flexibility, critical for our ADC linker designs.

9/9/2021

— Ms. Anna Weber, Senior Scientist (Germany)

Consistent lot quality of mPEG11-amine enabled smooth PEGylation reactions.

9/6/2022

— Dr. Daniel Clark, ADC Development Scientist (USA)

High conjugation efficiency was achieved using mPEG11-amine.

3/4/2022

— Dr. Sophie Laurent, Medicinal Chemist (France)

mPEG11-amine minimized side products across multiple reaction protocols.

2/11/2020

— Dr. Lucas Meyer, Chemist (Germany)

Extended PEG linkers created with mPEG11-amine enhanced solubility of ADC constructs.

— Dr. Thomas Lewis, Bioconjugation Scientist (USA)

mPEG11-amine supplied by BOC Sciences facilitated efficient modification of our biomolecules. Purity was excellent, and delivery was prompt, supporting our project timeline.

9/3/2019

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Gly-PEG3-amine | N-Butanoyl-L-homoserine lactone | Propargyl-PEG4-tos | Boc-gly-PEG3-endo-BCN | Boc-Aminooxy-PEG2-bromide | Azido-PEG4-t-butyl acetate | TCO-PEG12-NHS ester | Amino-PEG8-t-butyl ester | DBCO-Peg4-VC-PAB-MMAE | DBCO-PEG5-NHS ester | mPEG11-amine
Send Inquiry
Verification code
Inquiry Basket